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Gender-dependent disease severity in autosomal polycystic kidney
disease of rats. The impact of gender on the course of chronic renal failure
in polycystic kidney disease (PKD) has been under discussion for years.
Recently an animal model of autosomal dominant PKD in the rat became
available allowing this topic to be studied. The aim of this study was to
evaluate disease severity according to gender, and the occurrence of
anticipation and/or genetic imprinting. Male and female affected PKD rats
were crossed with respective Wistar-Ottawa-Karlsburg (WOK) rats. From
this P generation 26 affected Fl hybrids were obtained, which were then
backcrossed with WOK rats, resulting in 275 backcrosses (BC generation).
In BC rats the affected males had a significantly higher kidney weight,
worse histology and poorer renal function than the females. In the male,
but not the female rats of the BC generation, transmission from an
affected Fl mother resulted in significantly higher kidney weight, worse
histology and poorer renal function than when the gene was inherited
through an affected father. Since at the same time body and kidney weight
were higher in the respective unaffected males, the previous effect in the
affected rats might be due to a growth factor transferred by the mother's
milk. The sex of the P generation had no such impact on these parameters.
Thus our data provide no evidence for disease anticipation and genetic
imprinting (in the classical sense) in the PKD rats, and the assumption of
a gender-dependent disease expressivity is favored.
In 1989 we demonstrated that end-stage renal failure appears
earlier in men than in women with adult autosomal dominant
polycystic kidney disease (PKD) (median age: 52.5 vs. 58.0 years)
[1]. These findings were supported [1, 2] and reconfirmed recently
[3] by data from the Australian and New Zealand Combined
Dialysis and Transplant Registry. Also Gabow et a! [4] reported
that in patients having the PKD1 gene, male gender resulted in a
more rapid loss of renal function. This gender-dependent accel-
eration of the disease process might be explained by gender-
dependent disease expressivity.
In contrast, Bear et a! [5] could not confirm this gender
difference when analyzing patients having the PKD1 gene. They
noted, however, that end-stage renal disease (ESRD) was related
to the gender of the parent transmitting the disease. ESRD
occurred earlier (50.5 vs. 64.8 years) in patients having inherited
the disease from their mother than from their father. This
observation would be consistent with a genetic imprinting effect,
that is, the differential modification of genetic material depending
on whether inheritance is from the male or female parent.
Recently Fick, Johnson and Gabow provided evidence for both
genetic imprinting and disease anticipation, that is, an earlier
onset and increased disease severity in successive generations [61.
Anticipation was noted, however, in only 53% of the informative
families, if anticipation was defined as a 10-year-earlier onset of
ESRD.
Thus there is both evidence for disease anticipation and genetic
imprinting. Furthermore a sex-dependent disease expressivity
cannot be ruled out. One approach to gain more insight into these
features would be to analyze these aspects in a suitable animal
model of PKD.
In 1989 Kaspareit-Rittinghausen et al reported on a rat model
exhibiting autosomal dominant PKD [7, 8]. These rats develop
histological lesions comparable to human PKD and progress to
ESRD, though slower than described initially [9—15]. Progression
can be accelerated by unilateral nephrectomy [16]. In the intial
reports [17, 18] hypertension had been mentioned, a finding which
subsequently could not be confirmed [19]. The most striking
observation in this model, however, was that female rats exhibiting
renal cysts did not develop renal failure up to the age of six
months [15] or even 44 weeks [9]. This is clearly different from
what had been observed in male animals, in which already at the
age of two months increased serum urea concentrations occur [9,
15]. Thus a significant gender difference with respect to the
development and progression of renal failure seems to exist in the
PKD rat model.
These findings in humans and animals prompted us to examine
in the PKD rat model the severity of the renal degeneration
according to gender, and the presence of disease anticipation or
genetic imprinting.
Animals and methods
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Homozygous unaffected and heterozygous affected Han: SPRD
rats exhibiting PKD were originally obtained from the Central
Institute for Laboratory Animal Breeding in Hannover, Germany,
and highly inbred WOK (Wistar-Ottawa-Karlsburg) rats from the
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Diabetes Research Center in Karlsburg, Germany. The PKD rats
were transferred into our laboratory when inbred to the 11th
generation, while the WOK rats were already inbred up to the 21st
generation [10, 20]. The PKD rats were selectively inbred by us up
to their 19th generation before starting this experiment. One
affected male and one female PKD rat (P) was crossed with
respective WOK rats in order to obtain (PKD X WOK) Fl
hybrids from which 18 male and 8 female Fl hybrids were
backcrossed onto their respective WOK mate. These [(PKD X
WOK)(F1 X WOK)] first backcross hybrids (BC) were then
studied.
All animals had free access to tap water and standard rat chow
containing 19% protein (Altromin 1934®, Lage, Germany). All
rats were sacrificed when the BC offspring had reached an age of
two months. Body weight was taken, and under anesthesia (ket-
amine and diazepam) the animals were bled from the aorta, the
kidneys were removed and fixed in formaldehyde after wet wt had
been obtained. From the blood samples serum urea concentration
was determined by standard laboratory methods.
The carrier status of each animal was established by histology.
The extent of the cystic formation was assessed by using a scoring
system:
Grade 1. Occasionally small and/or medium-sized cysts (diam-
eter up to that of 2 glomeruli), cysts only in a few visual fields;
Grade 2. Few small and/or up to 5 medium-sized cysts per visual
field, rarely large cysts (diameter larger than 2 glomeruli), cysts
not in every visual field;
Grade 3. Several small and/or up to 10 medium-sized cysts
(diameter up to that of 2 glomeruli) per visual field, few large cysts
(diameter larger than 2 glomeruli), cysts in every visual field;
Grade 4. A large number of small and/or medium-sized and/or
at least 2 large cysts per visual field, cysts in every visual field,
occurrence of 'network-like structures' consisting of large con-
nected cysts.
The histological examination and the scoring was performed by
two independent observers in a blinded fashion. In all cases
agreement on the diagnosis and the histological grading was
obtained.
For data evaluation the SAS system was used. The following
procedures were applied: PROC FREQ (Fisher's exact test for 2
X 2 or larger tables) [21], PROC GCHART (graphical presenta-
tion of data) [22}, PROC TTEST (t-test) [23] and PROC UNI-
VARIATE (mean and SD) [241. All data are given as 5 SD.
Results
From 26 pairs of Fl animals 292 BC rats were obtained, of
which 17 died during the first six weeks of life (range 0 to 2/litter).
Thus 275 were entered into final evaluation. The overall effective
litter size was 10.6 2.8 animals. In the 275 animals the mode of
inheritance was autosomal dominant, as the number of rats
expected to be PKD positive or negative and the actual figures did
not differ (PKD: positive N = 151 and negative N = 124; Fisher's
exact test, P = 0.143). The overall gender distribution (males N =
133, females N = 142; Fisher's exact test, P 0.382) and the
distribution of affected and unaffected animals within both sexes
(males: affected N = 74 and unaffected N = 59; females: affected
N = 77 and unaffected N = 65; Fisher's exact test, P = 0.455) was
not skewed.
Gender of the Fl animal transmitting the PKD gene had a
significant impact on body wt (Table 1) and kidney mass (wet wt
Fl gene transmission
Maternal Paternal
BC offspring N ii SD N i SD P
Body weight g
affected male 28 321 23 46 305 28 0.0135
unaffected male 19 339 24 40 308 26 0.0001
affected female 26 216 21 51 211 15 0.2198
unaffected female 22 210 13 43 208 14 0.4819
Kidney mass g
affected male 28 5.4 0.9 46 4.7 0.9 0.0012
unaffected male 19 2.3 0.2 40 2.1 0.2 0.0015
affected female 26 2.3 0.4 51 2.3 0.3 0.2944
unaffected female 22 1.4 0.1 43 1.4 0.2 0.9049
Serum urea mg/d!
affected male 28 53.1 10.9 46 46.6 7.0 0.0072
unaffected male 19 36.8 2.6 40 36.1 2.9 0.3547
affected female 26 36.9 5.2 51 38.6 4.7 0.1587
unaffected female 22 34.0 3.9 43 38.2 3.8 0.0001
N is number of animals.
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of the left and right kidneys; Table 1). In affected and unaffected
male BC rats maternal gene transmission resulted in higher body
wt and larger kidneys than in those rats in which paternal gene
transmission had occurred. No such differences were noted in
female offspring.
The observation of a higher kidney weight after maternal gene
transmission suggests the occurrence of more severe histological
lesions in the affected male rats. Significantly higher disease
severity scores were found in affected male rats inheriting the
PKD gene from their mother (Fig. 1; Fisher's exact test, P
0.006). Such a finding could not be observed in affected female
rats (Fisher's exact test, P = 0.222). Overall, affected female BC
animals had smaller cysts in comparison to affected male BC
animals (Fisher's exact test, P < 0.001).
Serum urea values in affected male BC offspring of affected Fl
Table 1. Body weight and dney mass according carrier status and
parental id offspring gender
Scoring I
/
Male Male Female Female
Offspring
Fig. 1. Percentage distribution of disease severity according to parental
gender (Fl) and that of the offspring after histological scoring. Symbols are:
() maternal gene transmission; (•) paternal gene transmission).
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Table 2. Impact of der of the P generation on kidney mass, body weight and serum urea concentration
Affected animals
fe fe
ma fe
fe ma
ma ma
fe fe
ma fe
fe ma
ma ma
Unaffected animals
fe fe
ma fe
fe ma
ma ma
ma 13 2.3 0.22
ma 6 2.2 0.14
ma 17 2.1 0.24
ma 23 2.1 0.19
0.282 342 28.1
331 8.1
081.8 310 32.6
306 20.5
0.145 213 13.5
209 13.5
0.079 208 15.1
206 11.4
0.212 36.4
37.7
0.579 36.2
35.9
0,577 34.5
33.9
0.477 39.1
37.1
3.1
4.3
3.9
3.6
Abbreviations are: P. Fl and BC are defined in Methods section; fe, female, ma, male.
mothers were significantly higher when compared with affected
male BC offspring of affected Fl fathers (Table 1). With respect to
serum urea unaffected BC female offspring revealed a significant
difference according to parental gender, though the magnitude of
the difference was small.
Furthermore we checked the data for disease anticipation
taking the gender of the P generation into consideration. After
dividing each of the groups analyzed in Table 1 according to
gender of the P parent, no major significant difference between
the different groups of animals could be observed (Table 2). A
marginally significant difference occurred with respect to body wt
between the groups, in which either a male or a female transmit-
ted the gene via a female onto a male animal. Also, in the affected
groups no difference could be detected with respect to the scoring
of the renal histology (Fisher's exact test, P ranging from 0.505 to
0.836).
Discussion
Our data clearly demonstrate that there is a considerable
gender difference between affected male and female rats with
respect to their renal function, kidney mass (Table 1) and degree
of histological renal involvement (Fig. 1). Furthermore, a consid-
erable impact of parental gender (Fl generation) on functional
and histological parameters was noted, with a maternal gene
transmission resulting in a more pronounced disease severity (Fig.
1, Table 1). On the other hand, no such difference could be
revealed for the impact of gender on the P generation (Table 2).
Thus these data provide priliminary evidence for a genetic
imprinting effect and gender-dependent disease expressivity, but
not for disease anticipation.
In addition, we could successfully transfer the PKD gene from
one rat strain to another, that is, from a Sprague-Dawley to WOK
background, resulting in the same histological and functional
changes as described previously. Finally the autosomal dominant
type of inheritance and a normal gender distribution was con-
firmed.
In a recent review on genetic heterogeneity, anticipation, and
imprinting in PKD, Zerres and Rudnik-SchOneborn [25] pointed
out that the number of pediatric patients suffering from the
recessive or dominant type of PKD is about the same in Germany
(129 and 143, respectively). Already in 1993 Fick et a! [26] and
Zerres, Rudnik-SchOneborn and Deget [27] reported on the
occurrence of autosomal dominant PKD in utero and in the
neonatal period. Surprisingly, the parents transmitting the auto-
somal dominant type of PKD to the children with early onset most
often show the typical age at onset of the disease. Furthermore,
these authors noted the clustering of the early onset cases in the
same families and the predominance of maternal gene transmis-
sion. This high variability in disease severity, not only among but
also within families, together with the fact that up to one third of
PKD patients have no family history, probably reflecting unsus-
pected disease in earlier generations, suggested the occurrence of
anticipation. This hypothesis, first made by Gabow et al [4], has
recently been confirmed by Fick et al [6], who noted a 10-year-
earlier onset of ESRD in 50 out of 94 informative families (53%).
A similar percentage of anticipation (45%) was published in an
abstract by Torra et a! [28].
Moreover, a gender effect seems to be operative in the trans-
mission of early onset autosomal dominant PKD since both Fick
et al [26] and Zerres et al [27] noted that the transmitting parent
in the pairs with anticipation was more often the mother than the
father. Similarly, Bear et al [5] reported that ESRD occurred
earlier (50.5 vs. 64.8 years) in patients having inherited the disease
from their mother than from their father.
This gender-dependent transmission of both the early onset and
the anticipation in autosomal dominant PKD resembles what had
already been found in other genetic diseases, where an epigenetic
modification of the disease locus, known as genetic imprinting,
has been demonstrated to play a role in changing the degree of
severity or the appearance of the disease [29]. Neither genetic
imprinting nor the possible interaction of the PKD gene with
other modif'ing genes, not yet identified, can be excluded at this
stage. An effect of changes in the gene itself, as it occurs with
P Fl BC
Kidney mass g Body weight Serum urea mg/dl
N x SD P x SD Px SI) P
ma 11 5.7 0.64
ma 17 5.2 0.94
ma 21 4.8 0.79
ma 25 4.7 1.07
fe 14 2.4 0.43
fe 12 2.2 0.31
fe 21 2.4 0.26
fe 30 2.3 0.34
0.107 331 14.8
314 24.4
0.626 311 28.0
300 28.1
0.195 219 23.8
212 16.0
0.082 215 15.0
207 14.8
0.046 56.0
51.2
0.189 47.9
45.5
0.395 36.1
37.8
0.065 38.4
38.7
fe fe fe 6 1.4 0.08
ma fe fe 16 1.4 0.09
fe ma fe 24 1.4 0.19
ma ma fe 19 1.4 0.11
5.7
13.1
7.0
7.1
5.2
5,3
4.2
5.1
2.6
2.7
3,4
2.6
0.187
0.260
0.500
0.861
0.335
0.737
0.751
0.086
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Referencesheritable unstable DNA, might offer the best explanation for the
above observations [30, 31].
Data collected in the PKD rat model can contribute to the
understanding of genetic mechanism underlying the above obser-
vations. Although the number of BC rats in the present study is
quite high (N = 275), the number of parent animals (P and Fl
generation) is limited (N = 2 and N = 26, respectively). Thus
despite a random selection of the P animals there could be a
selection bias due to the small number of rats. Furthermore, the
number of parent-offspring sets might be insufficient to confirm or
exclude a possible role of anticipation. One has to keep in mind
that all rats (P, Fl and BC rats) were sacrified when the BC
generation had reached the age of two months. Therefore, a
longitudinal comparison of the parameters under study cannot be
performed.
Despite these caveats it can be concluded that, with respect to
parental gender, heterozygous male rats inheriting the disease
gene from the mother exhibit an earlier onset and/or more severe
form of PKD (Fig. 1, Table 1). This suggests that the maternal
effect could be due to the existence of a "growth factor" trans-
mitted from the affected female parent (Fl) to the BC offspring
via the placenta or during suckling.
Recently Lakshmanan and Eysselein [32] noted a hereditary
error in epidermal growth factor (EGF) prohormone metabolism
in the PKD rat model. They found massive amounts of 66 kD
EGF prohormone in cyst fluid, suggesting that EGF and/or its
prohormone might function as a cystogen. As EGF is secreted in
rat milk [33], is protected by milk-borne peptidases in the gut from
destruction [34], and influences the body wt of pups [35] with its
effect being androgen-dependent [36], most of the observed
differences in our study could be explained by an aberrant
metabolism of EGF or its prohormone. Whether the early effects
of such a growth factor persist throughout life is unclear. On the
other hand, such a factor would favor the hypothesis of a
sex-dependent disease expressivity in PKD, while the assumption
of genetic imprinting is not necessary to explain our findings.
In the fawn-hooded rat, another hereditary model of chronic
renal failure, a similar gender difference with respect to the
occurrence of focal segmental glomerular sclerosis, proteinuria
and hypertension has been observed [37, 38]. Further gender
differences in hereditary and non-hereditary renal diseases both in
humans and in animals have been reviewed recently [39].
In conclusion, our data support the notion that there is a
sex-dependent expressivity of the renal disease in the PKD rat, as
in other animal models of renal failure. The occurrence of genetic
imprinting is not supported by our data and disease anticipation
could not be proven.
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